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Summary Colonic tumour cells possess a cell surface protease capable of binding 9-aminoacridine to its
active centre, thus locating cells when viewed under a fluorescence microscope. In vivo and in frozen sections,
the enzyme is masked by a protein inhibitor. This inhibitor can be displaced by formaldehyde fixation of the
tissue and then replaced by adding a fresh extract of colon or lung tissue. The inhibitor is modified by
oxidation; provided by air, oxidized glutathione or potassium permanganate, resulting in a change in
conformation in the inhibitor and this then results in the enzyme binding the fluorescent probe. The effect of
oxidation can be reversed by dithiothreitol. It is proposed that these changes are brought about by a
disulphide exchange acting on the inhibitor which indirectly controls the activity of the cell surface enzyme in
vivo.
The steps described above can be conveniently followed on sections of tissue mounted on a microscope
slide; this has the advantage that the same cells can be monitored during a sequence of reactions. It is
believed that these techniques could well be applied to other enzyme systems than the tumour protease
described in this study.
This paper concerns a protease which is associated with cells
capable of migration and in particular tumour cells (Steven
et al., 1985, 1986a,b, 1987; Johnson et al., 1986). The
enzyme is referred to as guanidinobenzoatase (Steven & Al-
Ahmad, 1983), has been purified by affinity chromatography
(Steven et al., 1986b) and has been shown to be a protease,
cleaving the arginyl bond in the peptide GlyArgGlyAsp
(Steven et al., 1986c) considered to be the link region for
attachment of cells to fibronectin (Piersbacher & Ruoslahti,
1984). Previous studies have been concerned with the kinetics
of inhibition of guanidinobenzoatase (Steven et al., 1985;
Steven & Al-Ahmad, 1983) in solution and the application of
these data to the selection of fluorescent competitive
inhibitors which may be used to locate cells possessing this
enzyme (Steven et al., 1985, 1986a) in formaldehyde fixed,
wax embedded sections and resin embedded sections (Steven
et al., 1986b). We now present evidence from a study of
fresh frozen sections demonstrating the presence of inhibitors
of guanidinobenzoatase in vivo which control the activity of
this cell surface enzyme. These inhibitors combine with the
enzyme to form an inactive latent form of guanidino-
benzoatase which is incapable of binding the fluorescent
probes used to detect this enzyme. To illustrate this
situation, we have chosen to employ frozen sections of
human colonic tumours as an experimental system. The
evidence is presented in the form of fluorescent micrographs
which have been obtained after treating the sections with 9-
aminoacridine, a successful probe for the active centre of
guanidinobenzoatase (Steven et al., 1985, 1986a). Tumour
cells with active enzyme fluoresce yellow (Steven et al., 1985,
1986c) whilst tumour cells with inhibited enzyme appear
green-blue and do not fluoresce. The frozen tumour section
thus replaces the reaction vessel in monitoring for the
presence or absence of an inhibitor in situ on the cell surface
protease. This test system has the advantage that the same
cells can be repeatedly examined after a sequence of
reactions involving the activation or inhibition of a defined
enzyme, in this case guanidinobenzoatase. The same
principle can be applied to other enzymes, for example
alkaline phosphatase (Steven & Burby, 1988), using a
suitable fluorescent probe. It would appear that the
techniques described in this paper could be applied to cell
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surface receptors or to any specific molecule with an affinity
for low molecular weight ligands.
The results of this study provide evidence for the presence
of inhibitors of guanidinobenzoatase in vivo which can be
modified by disulphide exchange reactions leading to
reversible control of enzymic activity. In this case, the
disulphide exchange has been shown to directly affect the
structure of the inhibitor so that it can no longer react with
the guanidinobenzoatase. Earlier studies (Steven &
Podrazky, 1978a, b, 1979) demonstrated that disulphide
exchange had a direct effect on trypsin-like enzymes. The
later extensive studies on the role of disulphide exchange in
collagenase inhibition confirmed and greatly extended these
observations (Tschesche & Macartney, 1981; Macartney &
Tschesche, 1983a,b, c,d).
Materials and methods
Fresh frozen sections of human colonic tumours were
obtained immediately after surgery. In all we examined 190
frozen sections obtained from colonic tissue taken from 6
patients. Material for wax embedding was fixed in 10% w/v
formaldehyde in isotonic saline, embedded, sectioned and
dewaxed by conventional histopathological techniques.
Formaldehyde treatment of frozen sections was carried out
for 18 h in 10% w/v formaldehyde in isotonic saline.
Homogenates of human lung, liver, heart and colon were
prepared by employing an Ultra-Turrax homogeniser on
chopped tissue suspended in isotonic saline. The cell debris
was removed by centrifugation and the supernatant extract
(. 1 mg proteinml 1) was used in the inhibition exchange
experiments.
Oxidized glutathione, 4-methylumbelliferyl-p-guanidino-
benzoate, N-ethylmaleimide, dithiothreitol, potassiumperman-
ganate, oxalic acid and 9-aminoacridine were purchased from
Sigma Chemical Company, St. Louis, Mo., USA. Aprotinin
(trasylol) was a generous gift from Bayer Chemical Company.
Methods
The fluorescent staining technique employing 9-
aminoacridine has been fully described (Steven et al., 1985).
Essentially, cells which posses guanidinobenzoatase in a form
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Figure 1 Fresh frozen section. No cells bind 9-aminoacridine
due to the presence ofthe inhibitor. ( x 250).
100
90
> 80
'-
0
0
5E
N 70 c
w
60
50
Figure 2 Formaldehyde-treated frozen section. The tumour cells
exhibit yellow surface fluorescence in the absence of inhibitor.
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Figure 3 Inhibition of mouse guanidinobenzoatase by
incremental additions of human lung extract, assayed with 4-
methylumbelliferyl-p-guanidinobenzoate.
which can bind the 9-aminoacridine fluoresce a bright yellow
on a blue background.
The displacement of the inhibitor from the latent enzyme
was achieved by treatment with formaldehyde (see above) or
by treatment for 2h at 16°C with oxidized glutathione
(10-2M), dissolved in isotonic saline, followed by 30min
washing in isotonic saline. Treatment with dithiothreitol
(10-2M) dissolved in isotonic saline was for 2h followed by
a 2min wash in isotonic saline. Alternatively, oxidation was
carried out by placing the slides in 0.1 M potassium perman-
ganate for 2min followed by bleaching in 1% aqueous oxalic
acid for 2min and raising the pH to 7.4 with isotonic saline
containing 0.1 M NaHCO3 for 2min. The replacement of
inhibitor was achieved by covering the section on the slide
with tissue extract and leaving for 18h at 16°C in a wet box,
followed by washing off the excess tissue extract with
isotonic saline. After each of these reactions the sections
were monitored by staining with 9-aminoacridine.
Simple kinetic experiments were designed to demonstrate
inhibition of mouse guanidinobenzoatase (Steven &
Al-Ahmad, 1983) as previously described (Steven et al.,
1986a) employing 4-methylumbelliferyl-p-guanidinobenzoate
1 106M [S]
Figure 4 Non-competitive inhibition of mouse guanidino-
benzoatase, assayed with incremental additions of 4-
methylumbelliferyl-p-guanidinobenzoate: (a) in the absence of
inhibitor; and (b) in the presence of inhibitor (100pl lung
extract).
as substrate. The object of these experiments was to define
whether the inhibition was competitive or non-competitive.
In the plot presented in Figure 4 the change in fluorescence
due to the production of methylumbelliferone was used
rather than the molarity of the product in the values of (1/v).
Results and discussion
Very few fluorescent cells were observed (Figure 1) when
fresh frozen sections of colonic tumour were stained directly
with 9-aminoacridine and examined by fluorescent
microscopy. Yet, when the same or identical sections were
pretreated with formaldehyde prior to the staining with 9-
aminoacridine, the tumour cells were clearly stained (Figure
2). Similar results to those shown in Figure 2 were obtained
when formaldehyde-fixed tissues in wax embedded sections
were stained with 9-aminoacridine. It was previously shown
that a similar situation was found in pancreatic acinar cells
(Steven et al., 1986c) and it was demonstrated that
formaldehyde displaced an inhibitor from the guanidino-
benzoatase. Affinity systems were used to isolate this protein162 F.S. STEVEN et al.
Figure 5 Frozen section exposed to air for 3 weeks at -20°C. Figure 6 Fresh frozen section treated with oxidized glutathione
Tumour cells exhibit cell surface staining of guanidino- (10-2 M). The tumour cells now stain strongly. ( x500).
benzoatase. (x 250).
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Figure 8 Fresh frozen section treated with potassium
permanganate 101 M. Tumour cells now stain strongly. ( x 250).
Figure 7 Schematic representation of the reversible disulphide
exchange mechanism for control of tumour cell surface
guanidinobenzoatase. The inhibitor can only bind to the enzyme
when in the reduced state.
inhibitor from pancreatic and liver tissue; the purified
inhibitor was then exchanged with the cell surface bound
inhibitor (Steven et al., 1986c).
The evidence presented in this study clearly shows that the
colonic tumour cells in vivo are unable to bind 9-
aminoacridine due to the presence of an inhibitor which can
be displaced by formaldehyde without interfering with the
enzyme's ability to bind 9-aminoacridine (Figure 2). We
believe the formaldehyde either cross-links amino groups
leading to an inactive conformation of the inhibitor or
modifies thiol groups in the inhibitor with consequent loss of
inhibitory action.
We examined the possibility of exchanging inhibitors on
the colonic tumour cells. We observed that extracts of human
heart and liver did not provide suitable inhibitors to block
the arrival of 9-aminoacridine at the active centre of
guanidinobenzoatase; the results were similar to those in
Figure 2. On the other hand, extracts of lung and colonic
tissue did inhibit the binding of 9-aminoacridine to the
surface of tumour cells (results similar to Figure 1).
Independent studies showed that the heart and liver extracts
were able to block the binding of 9-aminoacridine to other
types of tumour (e.g. those found in liver) which indicated
the presence of functional inhibitors in these extracts. We
were able to demonstrate by kinetic analysis, employing
purified guanidinobenzoatase in solution, that the heart and
liver extracts contained an inhibitor(s) of this enzyme. It is
also possible that variations in the thiol/disulphide
concentrations in these tissue extracts could contribute to the
observed effect of these extracts on cell surface guanidino-
benzoatase activity. We infer from these observations that
there are probably iso-enzymes of guanidinobenzoatase, each
having the ability to bind 9-aminoacridine but having
slightly different secondary and tertiary structures which may
be recognised by inhibitors associated with the cells of
different tissues. It is hoped to develop this aspect of the
work elsewhere. It is sufficient at this stage to state that the
inhibition of colonic tumour cell surface guanidino-
benzoatase is reversed by formaldehyde and can be regained
by addition of fresh inhibitor in the form of the tissue
extract. The observation that the natural inhibitor of colonic
tumour cell surface guanidinobenzoatase could be replaced
by a protein from the lung extract was confirmed by kinetic
analysis (Figures 3, 4) of the non-competitive inhibition of
guanidinobenzoatase in solution. It might be suggested thatINHIBITION OF TUMOUR-ASSOCIATED PROTEASE 163
the lung inhibitor was really aprotinin, a protein with a wide
range of inhibitory action against proteases. Commercially
available aprotinin (trasylol) failed to inhibit guanidino-
benzoatase, either in free solution or on the surface of
colonic tumour cells. Aprotinin can therefore be excluded
from the role of the inhibitor present in the lung extract.
The conclusion that the colonic tumour cell surface
guanidinobenzoatase is inhibited in vivo, based on the
evidence presented above (Figures 1, 2), raises a number of
questions as to how the tumour cell benefits from a latent
protease and what chemical mechanism might be exercised
by the cell to activate guanidinobenzoatase. Clearly, this
process is not a zymogen activation since the action of
formaldehyde is not a known zymogen-activation mechanism
and the inhibition has been demonstrated to be reversible by
addition of the tissue extracts. We consider it most likely
that the observed latency of guanidinobenzoatase could be a
form of migratory control mechanism which might be
altered by cell metabolism. A similar mechanism involving
the pentose phosphate pathway has been described for the
control of collagenase inhibition (Tschesche & Macartney,
1981). In the present case, we consider that the extracellular
ratio of oxidised to reduce glutathione might provide the
conditions for disulphide exchange reactions (Steven &
Podrazky, 1987a,b, 1979) which could affect the
conformation of either the cell surface protease (Macartney
& Tschesche, 1982a,b, c,d) or its inhibitor, leading to a
change in enzymic potential. In our sections, we could
monitor such changes in enzyme potential by the ability of
the cell to bind 9-aminoacridine.
We therefore allowed frozen sections of colonic tumour to
remain at -20°C for 3 weeks in the presence of air and re-
examined these aged sections with 9-aminoacridine staining
(Figure 5). The tumour cells in the aged sections were now
able to bind 9-aminoacridine to their cell surface without
needing to displace the inhibitor by formaldehyde treatment
(cf. Figure 5 with Figures 1 & 2). Clearly the aging (possibly
by oxidation) had converted latent enzyme (initially
unstained) to active enzyme now able to bind 9-
aminoacridine (Figure 5). The hypothesis that an oxidation
reaction was involved in this conversion of latent to active
enzyme was confirmed by the action of both oxidized
glutathione and potassium permanganate. Fresh frozen
sections of tumour, when placed for 2h in oxidized
glutathione (10-2 M) dissolved in isotonic saline, followed by
washing for 30min in isotonic saline, bound 9-aminoacridine
(Figure 6). The tumour cells now behaved as though the
tissue had been treated with formaldehyde (see Figure 2) or
had been aged in air (Figure 5). We conclude that oxidized
glutathione activated the latent enzyme by an oxidation
reaction involving a disulphide exchange mechanism. The
oxidized glutathione was shown to have no effect on the
ability of formaldehyde-activated colonic tumour cells to
bind 9-aminoacridine (Figure 2). It therefore seemed likely
that the oxidizing action of glutathione and air had been on
the structure of the inhibitor leading to the inability of the
inhibitor to bind to the cell surface enzyme. This suggestion
was open to experimental investigation. We know that
frozen tumour sections have little ability to bind 9-
aminoacridine and that after prolonged exposure of these
sections to air (Figure 5) these tumour cells did bind the
fluorescent probe. At an intermediate period (e.g. 5-7 days)
the inhibitory moiety of the latent enzyme on the tumour
cells is partially oxidized and some binding of 9-
aminoacridine could be observed. Treatment of these
partially oxidized sections with oxidized glutathione led to
complete oxidation and complete expression of the enzyme's
ability to bind 9-aminoacridine (results similar to Figures 2
& 5). On the other hand, treatment of these partially
oxidized sections with dithiothreitol (10-2 M) in isotonic
saline for 2h led to the complete suppression of the tumour
cells' ability to bind 9-aminoacridine (results similar to
Figure 1). The presence of an excess of reducing thiol caused
a reversal of the activation produced by an excess of
disulphide or oxidizing agent. Clearly, the latency of tumour
cell surface guanidinobenzoatase, as revealed by the ability
to bind 9-aminoacridine, can be controlled by a disulphide
exchange mechanism. Independent studies showed that this
concentration of dithiothreitol had no inhibitory action on
the tumour cells' ability to bind 9-aminoacridine in
formaldehyde treated sections and we conclude that
disulphide exchange did not directly alter the properties of
the cell surface protease. In the case of latent tumour cell
surface guanidinobenzoatase, the effect of disulphide
exchange must be a modification of the structure of the
inhibitor. This alteration has an indirect effect on the ability
of the cells to bind 9-aminoacridine. Oxidation resulted in
the inhibitor being unable to bind to the enzyme and could
be reversed by the reducing agent, dithiothreitol. These
events are diagrammatically represented in the scheme
presented in Figure 7. Blocking of free thiols with N-
ethylmalimide did not result in activation of the cell surface
latent enzyme which indicated that inhibition was not
dependent on free thiols.
It could be argued that the activation of latent guanidino-
benzoatase on the surface of tumour cells by oxidized
glutathione might be due to some property of the peptide
other than its potential for oxidative disulphide exchange. In
order to clarify this question we replaced oxidized
glutathione by the oxidizing reagent 0.1M potassium
permanganate, for 2min in contact with the frozen sections.
Treatment of the frozen sections with potassium
permanganate demonstrated (Figure 8) the role of oxidation
in the conversion of the latent enzyme into the active form
of guanidinobenzoatase. Likewise, the addition of the lung
extract to the activated enzyme resulted in total inhibition of
the ability to bind 9-aminoacridine (same as Figure 1) and
this was reversed by treatment with formaldehyde. The
observations that exposure to air, oxidized glutathione and
potassium permanganate all resulted in cell surface protease
activation, whilst none of these agents had any affect on the
ability of formaldehyde treated sections to bind 9-
aminoacridine on the surface of tumour cells is presented as
evidence that these agents oxidize the inhibitor rather than
the enzyme. Kinetic experiments with the soluble enzyme,
assayed with 4-methylumbelliferyl-p-guanidinobenzoate,
demonstrated that oxidized glutathione and thiols had no
direct effect on this enzyme.
Previous studies of enzyme control have been concerned
with a disulphide bond linking the inactive enzyme to the
inhibitor (Steven & Podrazky, 1978a,b, 1979; Macartney &
Tschesche, 1983a,b,c,d). In these earlier reports, the active
enzyme was directly inhibited by added thiols which
mimicked the role of the naturally occurring inhibitors. The
present study is novel in that the evidence points to the
control of enzymic activity being mediated by a reversible
disulphide exchange taking place only in the inhibitor
molecule. This oxidative change results in the inability of the
inhibitor to bind to the cell surface guanidinobenzoatase and
the consequent binding of the fluorescent probe to the cell
surface. Since guanidinobenzoatase has been shown to
degrade fibronectin (Steven et al., 1986a), an increase in
extra-cellular oxidizing potential (e.g. oxidized glutathione)
could possibly promote reactivation of latent guanidino-
benzoatase in vivo and increase the potential of tumour cells
to migrate. This may relate to the observation that tumour
cell proliferation is often associated with a good blood
supply.
We believe the observations presented are the first
reported examples of the activation of a cell surface protease
by means of a disulphide exchange reaction. We also believe
this is the first example of a disulphide exchange taking
place in one molecule (the inhibitor) which has an indirect
effect on a second molecule (the enzyme) leading to a control
of a biological function of a tumour cell. Although it is not
known whether extracellular oxidation reactions in vivo164 F.S. STEVEN et al.
activate latent tumour guanidinobenzoatase, we have
demonstrated oxidized glutathione and molecular oxygen to
be capable of such an activation in vitro. We believe that if
such activation takes place in vivo, this would enable the
protease to degrade fibronectin at the cell surface and thus
enhance the cells' metastatic potential. The few positively
staining cells observed in frozen tumour sections stained
directly with 9-aminoacridine may be examples of cells with
metastatic potential in vivo.
F.S.S. wishes to thank the Cancer Research Campaign for generous
support.
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